Table of Contents

company-logo

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.

NeuroBo Pharmaceuticals Dividend Announcement

• NeuroBo Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on NeuroBo Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

NeuroBo Pharmaceuticals Dividend History

NeuroBo Pharmaceuticals Dividend Yield

NeuroBo Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing NeuroBo Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

NeuroBo Pharmaceuticals Financial Ratios

P/E ratio-0.87
PEG ratio-0.09
P/B ratio1.86
ROE-189.12%
Payout ratio0.00%
Current ratio2.41
Quick ratio2.41
Cash Ratio2.38

NeuroBo Pharmaceuticals Dividend FAQ

Does NeuroBo Pharmaceuticals stock pay dividends?
NeuroBo Pharmaceuticals does not currently pay dividends to its shareholders.
Has NeuroBo Pharmaceuticals ever paid a dividend?
No, NeuroBo Pharmaceuticals has no a history of paying dividends to its shareholders. NeuroBo Pharmaceuticals is not known for its dividend payments.
Why doesn't NeuroBo Pharmaceuticals pay dividends?
There are several potential reasons why NeuroBo Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will NeuroBo Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While NeuroBo Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is NeuroBo Pharmaceuticals a dividend aristocrat?
NeuroBo Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is NeuroBo Pharmaceuticals a dividend king?
NeuroBo Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is NeuroBo Pharmaceuticals a dividend stock?
No, NeuroBo Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy NeuroBo Pharmaceuticals stocks?
To buy NeuroBo Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy NeuroBo Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.